Archives

by in
Entry Author Date Location
Seattle Genetics Gets $138M in First-Year Sales of Cancer Drug 02/12/13 Seattle
Seattle Genetics Misses 1st Quarter Sales Estimate, But Sees $1B Future 05/08/12 Seattle
Seattle Genetics Gets New Commercial Boss for Early Days of Adcetris 02/23/12 Seattle
Seattle Genetics Sees Updated Side Effect Warning in Drug Label 01/13/12 Seattle
Seattle Genetics: The Next Litmus Test for High Priced Cancer Drugs 08/22/11 National
Seattle Genetics’ FDA Panel Preview: What You Need to Know This Week 07/12/11 Seattle
Seattle Genetics, On the Verge of Going Commercial, Seeks to Keep Its Scientific Soul 07/05/11 Seattle
Dendreon Moves Across Town, SeaGen Files FDA App, Alder Takes Road Less Traveled, & More Seattle Life Sciences News 03/03/11 Seattle
SEC Accuses Seattle Genetics Employee of Insider Trading 01/21/11 Seattle
Seattle Genetics Gets Some Love on National TV, as Cancer Drug Nears Market 01/14/11 Seattle
Editor’s Picks: The Best of 2010 From Xconomy Seattle 12/23/10 Seattle
Seattle Genetics’ Home Run, NanoString’s Diagnostics Foray, PATH’s 50-Cent Vaccine, & More Seattle-Area Life Sciences News 12/09/10 Seattle
Seattle Genetics, Millennium’s Encore: Souped-Up Antibody Looks Better in 2nd Trial 12/07/10 Seattle
Seattle Genetics, Millennium Report Groundbreaking Results With Drug for Hodgkin’s 12/05/10 Seattle
Seattle Genetics, Millennium Nail 2nd Straight Trial With “Empowered Antibody” For Cancer 10/11/10 Seattle
Seattle Genetics, Millennium Generate “Dream” Data With Empowered Antibody Drug for Cancer 09/27/10 Seattle
Larry Corey, Virus Hunter With Midwest Roots, Seeks to Unleash Health Innovation at Hutch 08/02/10 Seattle
Seattle Genetics’ Dark Horse, Gilead Beats Novartis, Oncothyreon Back in the Saddle, & More Seattle-Area Life Sciences News 06/24/10 Seattle
ZymoGenetics Gets Upstaged, Calistoga Cancer Drug Matures, Cramer Replaces Kraemer, & More Seattle-Area Life Sciences News 06/11/10 Seattle
Seattle Genetics Shows Re-Treatment Action 06/05/10 Seattle
Seattle Genetics, Growing Up in a Hurry With Millennium, Aims to Make Most of Cancer Drug 05/26/10 Seattle
Seattle Genetics Adds Patent to 2025 03/11/10 Seattle
Seattle Genetics Starts Lymphoma Trial 02/03/10 Seattle
Accelerator Slowed Down, Inside the Latest Seattle Genetics Deal, Ekos Finds New Use, & More Seattle-Area Life Sciences News 01/28/10 Seattle
Dendreon Recruits Aces to Board, Amgen Seeks to Raise Hit Rate, Lee Hood Startup Gets $30M, & More Seattle-Area Life Sciences News 10/15/09 Seattle
ZymoGenetics Plays Hardball, Targeted Genetics’ Legacy, Omeros Preps for Fall IPO, & More Seattle-Area Life Sciences News 08/27/09 Seattle
Seattle Genetics Trial Fills Up 08/24/09 Seattle
Seattle Genetics Gets $136M Total 08/13/09 Seattle
Seattle Genetics, Bucking the Trend, Recruits Hodgkin’s Patients at Warp Speed 08/12/09 Seattle
Seattle Genetics Starts New Trial 06/18/09 Seattle
Page 1 of 2 next page »